Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2975 of 3546 entries
View as:

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05047770 Org: User:
Start: 10/07/21 End: 08/31/22 Due: 08/31/23

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00871338 Org: User:
Start: 06/24/09 End: 12/09/10 Due: 12/09/11

Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00101985 Org: User:
Start: 10/31/04 End: 07/31/05 Due: 07/31/06

Study of Renin-angiotensin System in Mechanically Ventilated Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03212690 Org: User:
Start: 06/11/18 End: 07/08/19 Due: 07/08/20

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00828750 Org: User:
Start: 05/31/08 End: 02/28/11 Due: 02/28/12

Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

Phase: N/A Priority: Normal
NCT ID: NCT00950833 Org: User:
Start: 08/10/09 End: 10/27/10 Due: 10/27/11

Safety of Inhaled Zanamivir in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT01462487 Org: User:
Start: 07/31/11 End: 08/31/12 Due: 08/31/13

A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02798978 Org: User:
Start: 01/10/17 End: 10/13/17 Due: 10/13/18

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Phase: N/A Priority: Normal
NCT ID: NCT01957202 Org: User:
Start: 10/31/13 End: 02/28/14 Due: 02/28/15

GSK1349572 Mass Balance Study

Phase: N/A Priority: Normal
NCT ID: NCT00828763 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Rosiglitazone on Microalbuminuria in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00500955 Org: User:
Start: 04/30/00 End: 06/30/04 Due: 06/30/05

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Phase: N/A Priority: Normal
NCT ID: NCT03409107 Org: User:
Start: 03/05/18 End: 10/07/20 Due: 10/07/21

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04655976 Org: User:
Start: 12/08/20 End: 10/31/25 Due: 10/31/26

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00911157 Org: User:
Start: 06/30/08 End: 11/30/09 Due: 11/30/10

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00367679 Org: User:
Start: 11/30/06 End: 04/30/08 Due: 04/30/09

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00513565 Org: User:
Start: 09/13/07 End: 05/14/09 Due: 05/14/10

A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain

Phase: N/A Priority: Normal
NCT ID: NCT02100670 Org: User:
Start: 11/01/13 End: 03/22/15 Due: 03/22/16

The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00981409 Org: User:
Start: 07/31/07 End: 12/31/08 Due: 12/31/09

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00627458 Org: User:
Start: 02/01/08 End: 08/18/08 Due: 08/18/09

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01220128 Org: User:
Start: 04/11/11 End: 11/14/14 Due: 11/14/15

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

Phase: N/A Priority: Normal
NCT ID: NCT00197002 Org: User:
Start: 09/11/03 End: 01/16/06 Due: 01/16/07

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT00784550 Org: User:
Start: 12/31/08 End: 12/31/09 Due: 12/31/10

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT00500331 Org: User:
Start: 01/23/07 End: 02/14/08 Due: 02/14/09

Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath

Phase: N/A Priority: Normal
NCT ID: NCT00442468 Org: User:
Start: 04/30/07 End: 09/30/07 Due: 09/30/08

A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03170232 Org: User:
Start: 10/16/17 End: 11/15/18 Due: 11/15/19